Named on one round in the feed.
Since 2024-03-20
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Ultrahuman Ultrahuman sells health tracking devices and services, including continuous glucose monitors and performance analytics, primarily for health-conscious consumers. | Series B Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $35M | 2024-03-20 | [ PART ] |